Who are l-LV (dl-LV)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): L-cysteine, Acetyl-L-Carnitine, L-acetyl carnitine, Ademetionine tablet.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/l-lv-dl-lv.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

l-LV (dl-LV) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

l-LV (dl-LV) (l-LV (dl-LV)) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid derivative. Area: Oncology.

phase 3 Amino acid derivative Leucine aminopeptidase Oncology Small molecule Live · refreshed every 30 min

Target snapshot

l-LV (dl-LV) (l-LV (dl-LV)) — Epidemiological and Clinical Research Information Network. L-LV is a synthetic amino acid derivative that acts as a competitive inhibitor of the enzyme leucine aminopeptidase.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
l-LV (dl-LV) TARGET	l-LV (dl-LV)	Epidemiological and Clinical Research Information Network	phase 3	Amino acid derivative	Leucine aminopeptidase
L-cysteine	L-cysteine	Louisiana State University Health Sciences Center Shreveport	marketed	Amino acid derivative	Cystine/glutamate transporter
Acetyl-L-Carnitine	Acetyl-L-Carnitine	Dong-A ST Co., Ltd.	marketed	Amino acid derivative / Metabolic agent	Carnitine palmitoyltransferase (CPT) system
L-acetyl carnitine	L-acetyl carnitine	University of Campania Luigi Vanvitelli	marketed	Amino acid derivative / Metabolic agent	Carnitine palmitoyltransferase (CPT) system
Ademetionine tablet	Ademetionine tablet	Abbott	phase 3	Amino acid derivative / Methyl donor	S-adenosylmethionine (SAM) pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid derivative class)

Epidemiological and Clinical Research Information Network · 1 drug in this class
Louisiana State University Health Sciences Center Shreveport · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). l-LV (dl-LV) — Competitive Intelligence Brief. https://druglandscape.com/ci/l-lv-dl-lv. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab